International Journal of Endocrinology

International Journal of Endocrinology / 2019 / Article

Research Article | Open Access

Volume 2019 |Article ID 1546131 |

Krisztián Sepp, Zsolt Molnár, Anna M. László, Tünde Alapi, László Tóth, Andrea Serester, Zsuzsanna Valkusz, Márta Gálfi, Marianna Radács, "Study of the Potential Endocrine-Disrupting Effects of Phenylurea Compounds on Neurohypophysis Cells In Vitro", International Journal of Endocrinology, vol. 2019, Article ID 1546131, 9 pages, 2019.

Study of the Potential Endocrine-Disrupting Effects of Phenylurea Compounds on Neurohypophysis Cells In Vitro

Academic Editor: Rosaria Meccariello
Received20 Sep 2018
Revised01 Nov 2018
Accepted15 Nov 2018
Published10 Feb 2019


Homeostatic disruptor agents, and endocrine disruptor compounds (EDC) specifically, can originate from agricultural and industrial chemicals. If they modify the adaptation of living organisms as direct (e.g., by altering hormone regulation, membrane functions) and/or indirect (e.g., cell transformation mechanisms) factors, they are classified as EDC. We aimed to examine the potential endocrine-disrupting effects of phenylurea herbicides (phenuron, monuron, and diuron) on the oxytocin (OT) and arginine-vasopressin (AVP) release of neurohypophysis cell cultures (NH). In our experiments, monoamine-activated receptor functions of neurohypophyseal cells were used as a model. In vitro NH were prepared by enzymatic (trypsin, collagenase) and mechanical dissociation. In the experimental protocol, the basal levels of OT and AVP were determined as controls. Later, monoamine (epinephrine, norepinephrine, serotonin, histamine, and dopamine) activation (10−6 M, 30 min) and the effects of phenylurea (10−6 M, 60 min) alone and in combination (monoamines 10−6 M, 30 min + phenylureas 10−6 M, 60 min) with monoamine were studied. OT and AVP hormone contents in the supernatant media were measured by radioimmunoassay. The monoamine-activated receptor functions of neurohypophyseal cells were modified by the applied doses of phenuron, monuron, and diuron. It is concluded that the applied phenylurea herbicides are endocrine disruptor agents, at least in vitro for neurohypophysis function.

1. Introduction

Nowadays, society is the most complex evolutionary scene, in which transactions are realized between human beings and their environment (including the atmosphere, hydrosphere, and lithosphere). In this relation, people modify their environment so as to maintain their existence (e.g., chemisation) [1]. Chemisation came to be as a result of the biological and ecological problems caused by the vast and ever increasing amounts of chemicals used in agriculture (pesticides, herbicides, and fertilizers) [2]. These chemicals are xenobiotics [3]. These days, persistent organic pollutants (POPs) are placed in the focus. Endocrine disruptor compounds (EDC) are a group of heterogeneous POPs, which can interfere with endocrine communication [4, 5]. Phenylurea herbicides as POPs inhibit photosynthesis and can be found as contaminants in surface water and groundwater [6, 7]. Phenylureas have been used in agriculture extensively because of their herbicidal properties [8]. Several of the chlorinated benzenes are known to be porphyrogenic, carcinogenic, and mutagenic in animals and humans [9]; EDC lead to anxiety and aggression in rats [10] and to predator avoidance and reproductive and social behaviors in fish [7].

Biological objects, in order to maintain their inner homeostatic balance, take inputs from their environment, which can induce system accommodation processes. This connection among the biotic and abiotic systems can materialize, e.g., via neuroendocrine communication [11]. The synthesis and release of endogenous oxytocin (OT) and arginine-vasopressin (AVP) can be induced by external stimuli from paraventricular, supraoptic, and suprachiasmatic nuclei. The nerve terminals in the posterior lobe of the pituitary gland store these peptide hormones and release them into blood vessels to provoke their biological functions [12, 13].

OT secretion induced by stimuli is inversely proportional to the inhibition of food intake and gastric motility and stimulates the release of somatostatin and gastrin [14]. On the other hand, the actions of OT modulate neuroendocrine reflexes to establish complex social behaviors [15]. Beyond its peripheral effects on reproductive organs, OT might have an effect on neurons responsible for the cognitive feelings of organisms [16]. It is known that AVP and OT affect social cognition, particularly the acquisition and retention of social recognition in rats and mice [17]. Both hypotension and extracellular fluid volume expansion appear to stimulate hypothalamic oxytocinergic neurons and OT secretion; in rats, OT increases blood pressure and pulse rate [18]. There are several published studies investigating the prosocial effects of OT in humans: behaviors that facilitate interpersonal relations, including trusting behavior, generosity, and cooperation [19, 20]. In the female reproductive system, the pregnant uterus is one of the traditional targets of OT [21]. Systematic OT could also act peripherally, stimulating smooth muscle cells of the male reproductive tract [20].

The peptidergic hormone AVP can also be released by external stimuli and plays roles as both neurotransmitter and neuromodulator in the brain [22]. AVP participates in the regulation of the cardiovascular system and water-electrolyte balance [23]. As an antidiuretic hormone, AVP regulates body osmolality, blood volume, and blood pressure [24]. From these studies, it is postulated that OT and AVP are crucial in the adaptation processes of living organisms [25].

In homeostatic balance, biogenic amines play an essential role in the regulation of AVP and OT. Biogenic amines (with the ability to activate or inhibit OT and AVP) are important in the response mechanisms to external inputs. It is well documented that neuronal systems contain biogenic amines, such as dopamine (DA), epinephrine (E), norepinephrine (NE), histamine (HA), and serotonin (5-HT). These mediators may contribute reinforcement information to influence memory performance [26, 27].

The monoamine-regulated OT and AVP release serves as a model for the study of neuroendocrine cell function [2832].

The integrity of neuroendocrine regulation can be controlled by following endocrine function attractors in in vitro models [33, 34]. Such regulation attractor in the OT and AVP secretion in vitro model is the monoamine-activated (agonistic or antagonistic) hormone secretion result.

Homeostatic regulation is modified by environmental factors (e.g., presence of EDC). The effects of EDC factors do not impact on the baseline but on the regulation of attractors [35]. When studying subtoxic or low-dose in vitro models, the regulation attractor should be followed for a worthy effect.

Our purpose was to present contemporary research in connection with the complex environmental stressors and their effects on the equilibrium process of living systems. We investigated the potential endocrine-disrupting effects of phenylurea herbicides (phenuron-PU, monuron-MU, and diuron-DU) on the monoamine-regulated oxytocin and vasopressin release of neurohypophysis cell cultures.

2. Materials and Methods

2.1. Experimental Protocol

Male Wistar rats (Charles River, Isaszeg, Hungary, medically certified) from different litters (weighing 120-250 g, aged 4-6 weeks at the beginning of the research) were used for hypophysis cell culture model systems. The animal care and research protocols were in full accordance with the guidelines of the University of Szeged, Hungary. During the research period, rats were kept under controlled relative air humidity of 55-65% and ambient temperature. Experimental animals lived under automated diurnal conditions (12 h darkness and 12 h light system) in groups of 10 animals. Standard pellet food and tap water were available ad libitum. After pentobarbital anaesthesia (4.5 mg/kg b.w. Nembutal, Abbott, USA), the animals were killed and decapitated. Neurohypophysis and adenohypophysis tissues were separated under a preparative microscope.

The neurohypophysis tissue was digested enzymatically with 0.2% trypsin (Sigma, Germany) in phosphate-buffered saline for 60 min and with 0.05% collagenase (Sigma, Germany) for an additional 60 min at 37°C. The enzymatic hydrolysis was stopped by the addition of 100 μg/mL trypsin inhibitor (Sigma, Germany). Mechanical disintegration of the tissue was performed on nylon blutex sieves (pore sizes 100, 80, and 48 μm in series). Cultures were controlled for both viability (>95%; trypan blue exclusion) and function, and the cell density was determined to be 2 × 105 cells/mL. The dispersed cells were placed onto 24-well plastic plates (Costar, USA) coated with 5% rat-tail collagen (Sigma, Germany). The starting cell density was cells/mL of medium (Dulbecco’s modified Eagle’s medium; Sigma, Germany) supplemented with 20% foetal calf serum (Gibco, USA) and 100 μg/L PENSTREP (Sigma, Germany). The cell cultures were maintained at 37°C in a humidified atmosphere of 5% CO2 in air. The culture medium was changed every 3 days. The 14-day-old neurohypophysis primary cell cultures were standardised by immunohistochemical methods (by relative incidence/unit plate-area of IR content OT or AVP cells), and the OT and AVP time-release kinetic activity was determined.

After these procedures, the basal OT and AVP levels were measured in neurohypophysis cell cultures.

2.2. Cell Culture Treatment Protocol (Figure 1)

The control samples were untreated and served as self-controls, which showed the basal release (60 min) of OT and AVP in NH.

The effects of PU, MU, and DU added to the NH for 60 minutes at concentration of 10−6 M were examined one by one [36]: PU CAS registry number: 101-42-8, DU CAS registry number: 330-54-1, and MU CAS registry number: 150-68-5 (Sigma, Germany). In our earlier studies, dose-dependent kinetics of phenylurea agents were determined, and the experimental doses were selected, because the saturation of receptor-binding sites depends on the affinity and number of receptor-binding molecules. Monoamine-activated G-protein receptors in NH were treated with 10−6 M (E, NE, 5-HT, HA, and DA) (Figures 2(a) and 2(b)) for 30 min [2832] and the same concentration (10−6 M) of phenylurea agents.

The combined treatment groups of the NH were treated firstly with monoaminergic compounds (for 30 min), then phenylurea compounds (for 60 min): (1) E + PU, NE + PU, 5-HT + PU, HA + PU, and DA + PU; (2) E + MU, NE + MU, 5-HT + MU, HA + MU, and DA + MU; and (3) E + DU, NE + DU, 5-HT + DU, HA + DU, and DA + DU.

The OT and AVP contents were detected in the supernatant media. From the supernatant media, 500 μL samples were removed by Gilson pipette at appropriate times and stored at −80°C until peptide radioimmunoassay (RIA) was performed to measure OT and AVP [10, 37].

A modified Lowry method [38] and Pierce BCA Protein Assay Kit (Thermo Fisher Scientific Inc., Rockford, USA) were used for the determination of total protein content.

2.3. Statistical Analysis

Pooled samples of neurohypophysis cell cultures (12 lots) were measured for OT and AVP hormone release in different EDC groups (control, PU, MU, and DU) by monoamine regulation (basal, E, NE, 5-HT, HA, and DA) in rats ( or 12 per group). Data were analyzed using mixed models [3941]. The monoamine regulation cycle was verified in mixed models for the comparison of 6 monoamine levels in the control groups for OT and for AVP. In the random intercept model, monoamine was used as the fixed factor and the lots as the intercept.

For the two investigated hormone data (OT, AVP), mixed models were applied with EDC and monoamine as fixed effects and random intercept for the lots. In the analysis models, the reference group was the control (no EDC treatment) basal (no monoamine) group.

Restricted maximum likelihood estimation and the Kenward-Roger method for adjusting the degrees of freedom were applied in all models with unstructured covariance matrix. Pairwise comparisons were estimated by least squares means using Šidák value adjustment. Model residuals were checked for normality assumptions.

Statistical analyses were performed in SAS (Version 9.3 SAS Institute Inc., Cary, NC, USA), where values of <0.05 were considered to indicate statistical significance [42].

3. Results

Stability of homeostatic systems can be followed by examining the endocrine regulation cycle. Therefore, the monoamine-activated OT/AVP release cycles were modelled by NH in vitro.

The result of PU, MU, and DU alone on neurohypophysis cell culture can be seen in Figures 3(a) and 3(b). OT release was not modified significantly by treatment with MU or DU, but PU ( OT/mg protein) can modulate it compared to the control ( OT/mg protein). AVP release did not show significant difference in the case of phenylurea agents.

OT and AVP release is an indicator of the monoamine-activated receptor cycle of neurohypophysis cells. The changing of these mechanisms was investigated using phenylurea agents (Figures 4 and 5). E ( OT/mg protein) activated OT secretion ( OT/mg protein) (Figure 4(a)) was significantly decreased by PU ( OT/mg protein) and DU ( OT/mg protein). Figure 4(b) shows the effects of phenylureas on NE activation. MU ( OT/mg protein) and DU ( OT/mg protein) significantly reduced the effect of NE ( OT/mg protein). OT exocytosis induced by 5-HT is shown in Figure 4(c). The used phenylurea agents caused only discrete changing of OT release in NH. In the case of HA ( OT/mg protein), only the combination with DU ( OT/mg protein) reduced the OT release significantly as seen in Figure 4(d). Figure 4(e) shows OT secretion for DA ( OT/mg protein), and again, only the combination with DU ( OT/mg protein) decreased it significantly.

In the case of AVP hormone, the E ( AVP/mg protein) activation was modified significantly by PU ( AVP/mg protein), DU ( AVP/mg protein), and MU ( AVP/mg protein) (Figure 5(a)). NE ( AVP/mg protein) induced AVP release (Figure 5(b)) was reduced by PU ( AVP/mg protein), MU ( AVP/mg protein), and DU ( AVP/mg protein). The effects of 5-HT ( AVP/mg protein) on NH cell AVP release (Figure 5(c)) were decreased by PU ( AVP/mg protein) and MU ( AVP/mg protein) and increased by DU ( AVP/mg protein). In Figure 5(d), it can be seen that the effect of HA ( AVP/mg protein) induced AVP release was diminished by PU ( AVP/mg protein) and DU ( AVP/mg protein). The DA ( AVP/mg protein) receptor-mediated AVP release (Figure 5(e)) in NH was significantly depressed by PU ( AVP/mg protein), MU ( AVP/mg protein), and DU ( AVP/mg protein).

4. Discussion and Conclusions

Bretaud et al. pointed out that exposures to sublethal concentrations of carbofuran, DU, and nicosulfuron have remarkable effects on acetylcholinesterase activity in the brain of goldfish (Carassius auratus) [43]. It is described that the herbicide MU inhibits growth and heterocyst formation in the nitrogen-fixing cyanobacterium Nostoc muscorum [44]. The results of Federico et al. showed direct genotoxic activity caused by the effects of PU, DU, and difenoxuron, as is demonstrated by the increasing number of chromosomal aberrations and sister chromatid exchange in Chinese hamster ovary and epithelial cell lines [45]. However, there is a serious lack of information on the effects of these agents on the endocrine cells.

In neuroendocrine communication, monoamines are known to be relevant regulators for the hormone release. Earlier studies have established that α1 receptors are involved in the E-induced increase in OT and AVP secretion, while the β2 receptor has a role in NE-mediated OT and AVP secretion. 5-HT1 and 5-HT2 receptors are involved in the 5-HT-induced increase in OT secretion while only 5-HT2 receptor has a role in the AVP secretion in NH. Our results show that H1 and H2 receptors are involved in the HA-induced increase in OT and AVP release in neurohypophysis cell cultures. D1 receptors are involved in the DA-induced enhancement of OT and AVP secretion. All mentioned monoamine receptors are G-protein-coupled, and cAMP-mediated mechanisms are induced in cells. OT and AVP hormone secretion is realized through protein kinase-C mechanisms (Figures 2(a) and 2(b)) [20, 46, 47].

In our in vitro model system, the EDC effects were detected by following hormone release via the disturbance of monoamine receptor function. The phenylureas alone did not show effects on basal hormone secretion of NH (Figure 3(b)), expect for PU on OT release (Figure 3(a)). However, the neurohypophysis cell function was modified by the combined treatment of monoamines and PU, MU, and DU. With regard to OT secretion, PU has an effect in epinephrine activation (Figure 4). MU has a stronger effect in NE activation. E, NE, HA, and DA activation was decreased significantly by the effect of diuron. In the phenylurea homologue line, the used DU was twice chloro substituted which can explain the difference in the endocrine effect [48, 49].

With regard to AVP release, the effects of used phenylureas were more expressed in all monoamine activation (Figure 5). PU had a significant effect on E, NE, 5-HT, HA, and DA monoamine activation. E activation was enhanced, and NE, 5-HT, and DA activation was reduced significantly by the used dose of MU (with the exception of HA activation). DU increased serotonin activation and decreased E, NE, HA, and DA monoamine activation significantly. These results are interesting in the case of AVP (as neurotransmitter and neuromodulator) because this hormone has an essential role in the endocrine-regulating body of osmolality, blood volume, blood pressure, cell contraction, and proliferation [23, 50]. The abovementioned hormones play a crucial role in horizontal homeostatic regulation; thus, altering the secretion of OT and AVP may influence the adaptation processes of living organisms to the external environment.

These findings confirm the classification of phenylureas as EDC. The environmental pollution by EDC may have chronic and/or acute effects on living organisms. Our results showed that the applied doses of phenylurea herbicides have direct and indirect effects on biological systems. Presumably, these phenylurea herbicides can disturb the association of monoamines to their receptors. The applied EDC per se play the role of possible modulator agents. In this context, neurohypophysis function is a crucial conditioning process.

E-, NE-, HA-, 5-HT-, and DA-activated hormone release mechanisms are mediated G-protein-coupled receptors [28, 29, 51]. These processes induce Gq/G11 proteins, which, in turn, activate phospholipase-C, which catalyses the hydrolysis of phosphatidylinositol 4,5-bisphosphate to yield inositol triphosphate and diacylglycerol [5254]. These signal transducers can enhance the intracellular [Ca2+] which is essential for OT and AVP expression. A detailed understanding of the mechanisms of hormone expression and functions is required to fully understand the workings of EDC, particularly the possibility that low doses of PU, MU, and DU might interfere with monoaminergic receptors.

In conclusion, the effects of phenylurea herbicides on monoamine-induced OT and AVP release show an EDC character based our results of an in vitro model system.

Data Availability

Requests for data, after initial publication, will be considered by the corresponding author.

Conflicts of Interest

The authors declare that they have no conflict of interest.

Authors’ Contributions

Krisztián Sepp and Zsolt Molnár wish it to be known that, in their opinion, the first two authors should be regarded as joint first authors.


This research was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TÁMOP-4.2.4.A/2-11/1-2012-0001 “National Excellence Program” and EFOP-3.6.1-16-2016-00008.


  1. H. Kitano, “Systems biology: a brief overview,” Science, vol. 295, no. 5560, pp. 1662–1664, 2002. View at: Publisher Site | Google Scholar
  2. E. Diamanti-Kandarikis, J. P. Bourguignon, L. C. Giudice et al., “Endocrine-disrupting chemicals: an Endocrine Society scientific statement,” Endocrine Reviews, vol. 30, no. 4, pp. 293–342, 2009. View at: Publisher Site | Google Scholar
  3. R. Melnick, G. Lucier, M. Wolfe et al., “Summary of the National Toxicology Program’s Report of the endocrine disruptors low-dose peer review,” Environmental Health Perspectives, vol. 110, no. 4, pp. 427–431, 2002. View at: Publisher Site | Google Scholar
  4. J. R. Roy, S. Chakraborty, and T. Chakraborty, “Estrogen-like endocrine disrupting chemicals affecting puberty in humans – a review,” Medical Science Monitor, vol. 15, pp. 137–145, 2009. View at: Google Scholar
  5. L. S. Birnbaum and S. Fenton, “Cancer and developmental exposure to endocrine disruptors,” Environmental Health Perspectives, vol. 111, no. 4, pp. 389–394, 2003. View at: Publisher Site | Google Scholar
  6. M. A. Oturan, M. C. Edelahi, N. Oturan, K. El Kacemi, and J. J. Aaron, “Kinetics of oxidative degradation/mineralization pathways of the phenylurea herbicides diuron, monuron and fenuron in water during application of the electro-Fenton process,” Applied Catalysis B: Environmental, vol. 97, no. 1-2, pp. 82–89, 2010. View at: Publisher Site | Google Scholar
  7. G. R. Scott and K. A. Sloman, “The effects of environmental pollutants on complex fish behaviour: integrating behavioural and physiological indicators of toxicity,” Aquatic Toxicology, vol. 68, no. 4, pp. 369–392, 2004. View at: Publisher Site | Google Scholar
  8. M. C. Gennaro, E. Marengo, V. Gianotti, and V. Maurino, “New strategies for the determination of phenylurea pesticides by gas chromatography with hot splitless inlet systems,” Journal of Chromatography A, vol. 910, no. 1, pp. 79–86, 2001. View at: Publisher Site | Google Scholar
  9. G. Pagano, M. Cipollaro, G. Corsale et al., “Comparative toxicities of benzene, chlorobenzene, and dichlorobenzenes to sea urchin embryos and sperm,” Bulletin of Environmental Contamination and Toxicology, vol. 40, no. 4, pp. 481–488, 1987. View at: Publisher Site | Google Scholar
  10. Z. Valkusz, G. Nagyéri, M. Radács et al., “Further analysis of behavioral and endocrine consequences of chronic exposure of male Wistar rats to subtoxic doses of endocrine disruptor chlorobenzenes,” Physiology & Behavior, vol. 103, no. 5, pp. 421–430, 2011. View at: Publisher Site | Google Scholar
  11. Z. Molnár, R. Pálföldi, A. László et al., “The effects of hypokalaemia on the hormone exocytosis in adenohypophysis and prolactinoma cell culture model systems,” Experimental and Clinical Endocrinology & Diabetes, vol. 122, no. 10, pp. 575–581, 2014. View at: Publisher Site | Google Scholar
  12. M. J. Brownstein, J. T. Russel, and H. Gainer, “Synthesis, transport, and release of posterior pituitary hormones,” Science, vol. 207, no. 4429, pp. 373–378, 1980. View at: Publisher Site | Google Scholar
  13. G. J. De Vries and R. M. Buijs, “The origin of the vasopressinergic and oxytocinergic innervation of the rat brain with special reference to the lateral septum,” Brain Research, vol. 273, no. 2, pp. 307–317, 1983. View at: Publisher Site | Google Scholar
  14. B. Olson, M. D. Drutarosky, M. S. Chow, V. J. Hruby, E. M. Stricker, and J. G. Verbalis, “Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats,” Peptides, vol. 12, no. 1, pp. 113–118, 1991. View at: Publisher Site | Google Scholar
  15. J. N. Ferguson, L. J. Young, and T. R. Insel, “The neuroendocrine basis of social recognition,” Frontiers in Neuroendocrinology, vol. 23, no. 2, pp. 200–224, 2002. View at: Publisher Site | Google Scholar
  16. J. A. Bartz, J. Zaki, N. Bolger, and K. N. Ochsner, “Social effects of oxytocin in humans: context and person matter,” Trends in Cognitive Sciences, vol. 15, no. 7, pp. 301–309, 2011. View at: Publisher Site | Google Scholar
  17. M. Yoshida, Y. Takayanagi, K. Inoue et al., “Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice,” The Journal of Neuroscience, vol. 29, no. 7, pp. 2259–2271, 2009. View at: Publisher Site | Google Scholar
  18. M. Petersson, P. Alster, T. Lundeberg, and K. Uvnas-Moberg, “Oxytocin causes a long-term decrease of blood pressure in female and male rats,” Physiology & Behavior, vol. 60, no. 5, pp. 1311–1315, 1996. View at: Publisher Site | Google Scholar
  19. Y. Ma, S. Shamay-Tsoory, S. Han, and C. F. Zink, “Oxytocin and social adaptation: insights from neuroimaging studies of healthy and clinical populations,” Trends in Cognitive Sciences, vol. 20, no. 2, pp. 133–145, 2016. View at: Publisher Site | Google Scholar
  20. G. Gimpl and F. Fahrenholz, “The oxytocin receptor system: structure, function, and regulation,” Physiological Reviews, vol. 81, no. 2, pp. 629–683, 2001. View at: Publisher Site | Google Scholar
  21. K. Uvnas-Moberg, “Antistress pattern induced by oxytocin,” Physiology, vol. 13, no. 1, pp. 22–25, 1998. View at: Publisher Site | Google Scholar
  22. M. W. Dünser, A. Mayr, H. Ulmer et al., “The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcardiotomy shock: a retrospective analysis,” Anesthesia & Analgesia, vol. 93, no. 1, pp. 7–13, 2001. View at: Publisher Site | Google Scholar
  23. C. L. Holmes, K. R. Walley, D. R. Chittock, T. Lehman, and J. A. Russel, “The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series,” Intensive Care Medicine, vol. 27, no. 8, pp. 1416–1421, 2001. View at: Publisher Site | Google Scholar
  24. C. L. Holmes, D. W. Landry, and J. T. Granton, “Science review: vasopressin and the cardiovascular system part 1 – receptor physiology,” Critical Care, vol. 7, no. 6, pp. 427–434, 2003. View at: Publisher Site | Google Scholar
  25. M. Simard and M. Nedergaard, “The neurobiology of glia in the context of water and ion homeostasis,” Neuroscience, vol. 129, no. 4, pp. 877–896, 2004. View at: Publisher Site | Google Scholar
  26. O. G. Nilsson, P. Brundin, and A. Björklund, “Amelioration of spatial memory impairment by intrahippocampal grafts of mixed septal and raphe tissue in rats with combined cholinergic and serotonergic denervation of the forebrain,” Brain Research, vol. 515, no. 1-2, pp. 193–206, 1990. View at: Publisher Site | Google Scholar
  27. K. Tully and V. Y. Bolshakow, “Emotional enhancement of memory: how norepinephrine enables synaptic plasticity,” Molecular Brain, vol. 3, no. 1, pp. 15–19, 2010. View at: Publisher Site | Google Scholar
  28. M. Radacs, M. Galfi, G. Nagyeri et al., “Significance of the adrenergic system in the regulation of vasopressin secretion in rat neurohypophyseal tissue cultures,” Regulatory Peptides, vol. 148, no. 1-3, pp. 1–5, 2008. View at: Publisher Site | Google Scholar
  29. M. Gálfi, M. Radács, A. Juhász, F. László, A. Molnár, and F. A. László, “Serotonin-induced enhancement of vasopressin and oxytocin secretion in rat neurohypophyseal tissue culture,” Regulatory Peptides, vol. 127, no. 1-3, pp. 225–231, 2005. View at: Publisher Site | Google Scholar
  30. M. Gálfi, T. Janáky, R. Tóth et al., “Effects of dopamine and dopamine-active compounds on oxytocin and vasopressin production in rat neurohypophyseal tissue cultures,” Regulatory Peptides, vol. 98, no. 1-2, pp. 49–54, 2001. View at: Publisher Site | Google Scholar
  31. M. Radács, A. H. Molnár, F. A. László, C. Varga, F. László, and M. Gálfi, “Inhibitory effect of galanin on adrenaline- and noradrenaline-induced increased oxytocin secretion in rat neurohypophyseal cell cultures,” Journal of Molecular Neuroscience, vol. 42, no. 1, pp. 59–66, 2010. View at: Publisher Site | Google Scholar
  32. M. Radács, M. Gálfi, A. Juhász et al., “Histamine-induced enhancement of vasopressin and oxytocin secretion in rat neurohypophyseal tissue cultures,” Regulatory Peptides, vol. 134, no. 2-3, pp. 82–88, 2006. View at: Publisher Site | Google Scholar
  33. T. Janáky, P. Szabó, Z. Kele et al., “Identification of oxitocyn and vasopressin from neurohypophyseal cell culture,” Rapid Communications in Mass Spectrometry, vol. 12, no. 22, pp. 1765–1768, 1998. View at: Publisher Site | Google Scholar
  34. A. M. Laszlo, M. Ladanyi, K. Boda et al., “Effects of extremely low frequency electromagnetic fields on turkeys,” Poultry Science, vol. 97, no. 2, pp. 634–642, 2018. View at: Publisher Site | Google Scholar
  35. C. G. Langton, “Artificial Life an Overview,” in Fifth Printing, a Bradford Book, The MIT Press, Cambridge, Massachusetts; London, England, 2000. View at: Google Scholar
  36. K. Sepp, A. M. Laszlo, Z. Molnar et al., “The role of uron and chlorobenzene derivatives, as potential endocrine disrupting compounds, in the secretion of ACTH and PRL,” International Journal of Endocrinology, vol. 2018, Article ID 7493418, 7 pages, 2018. View at: Publisher Site | Google Scholar
  37. G. Nagyeri, Z. Valkusz, M. Radacs et al., “Behavioral and endocrine effects of chronic exposure to low doses of chlorobenzenes in Wistar rats,” Neurotoxicology and Teratology, vol. 34, no. 1, pp. 9–19, 2012. View at: Publisher Site | Google Scholar
  38. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at: Google Scholar
  39. J. Singer and J. Willett, Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence, Oxford University Press, New York, NY, USA, 2003. View at: Publisher Site
  40. A. László, Longitudinal Studies: Repeated Measurements and Trends on Biomedical Data, [Ph.D. thesis], Department of Medical Physics and Informatics, University of Szeged, 2017.
  41. H. Brown and R. Prescott, Applied Mixed Models in Medicine, Second Edition, John Wiley & Sons Ltd., Edinburgh, UK, 2006. View at: Publisher Site
  42. SAS, SAS/Stat 9.3 User's Guide, SAS Institute Inc., Cary, NC, USA, 2011.
  43. S. Bretaud, J. P. Toutant, and P. Saglio, “Effects of carbofuran, diuron, and nicosulfuron on acetylcholinesterase activity in goldfish (Carassius auratus),” Ecotoxicology and Environmental Safety, vol. 47, no. 2, pp. 117–124, 2000. View at: Publisher Site | Google Scholar
  44. A. Vaishampayan, “Biological effects of a herbicide on a nitrogen‐fixing Cyanobacterium (blue‐green alga): an attempt for introducing herbicide‐resistance,” New Phytologist, vol. 96, no. 1, pp. 7–11, 1984. View at: Publisher Site | Google Scholar
  45. C. Federico, S. Motta, C. Palmieri, M. Pappalardo, V. Librando, and S. Saccone, “Phenylurea herbicides induce cytogenetic effects in Chinese hamster cell lines,” Mutation Research, vol. 721, no. 1, pp. 89–94, 2011. View at: Publisher Site | Google Scholar
  46. E. V. Gurevich, R. R. Gainetdinov, and V. V. Gurevich, “G protein-coupled receptor kinases as regulators of dopamine receptor functions,” Pharmacological Research, vol. 111, pp. 1–16, 2016. View at: Publisher Site | Google Scholar
  47. K. M. Dumais and A. H. Veenema, “Vasopressin and oxytocin receptor systems in the brain: sex differences and sex-specific regulation of social behavior,” Frontiers in Neuroendocrinology, vol. 40, pp. 1–23, 2016. View at: Publisher Site | Google Scholar
  48. L. B. Moreira, G. Diamante, M. Giroux et al., “Impacts of salinity and temperature on the thyroidogenic effects of the biocide diuron in Menidia beryllina,” Environemental science & technology, vol. 52, no. 5, pp. 3146–3155, 2018. View at: Publisher Site | Google Scholar
  49. C. N. P. Boscolo, T. S. B. Pereira, I. G. Batalhão, P. L. R. Dourado, D. Schlenk, and E. A. de Almeida, “Diuron metabolites act as endocrine disruptors and alter aggressive behavior in Nile tilapia (Oreochromis niloticus),” Chemosphere, vol. 191, pp. 832–838, 2018. View at: Publisher Site | Google Scholar
  50. E. Kozniewska and K. Romaniuk, “Vasopressin in vascular regulation and water homeostasis in the brain,” Journal of Physiology and Pharmacology, vol. 59, pp. 109–116, 2008. View at: Google Scholar
  51. S. Trumpp-Kallmeyer, J. Hoflack, A. Bruinvels, and M. Hibert, “Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors,” Journal Medicinal Chemistry, vol. 35, no. 19, pp. 3448–3462, 1992. View at: Publisher Site | Google Scholar
  52. M. J. Shipston and D. L. Armstrong, “Activation of protein kinase C inhibits calcium-activated potassium channels in rat pituitary tumour cells,” Journal of Physiology, vol. 493, no. 3, pp. 665–672, 1996. View at: Publisher Site | Google Scholar
  53. S. R. Rawling, “Pituitary adenylate cyclase-activating polypeptide regulates [Ca2+]i and electrical activity in pituitary cells through cell-type-specific mechanisms,” Trends in Endocrinology & Metabolism, vol. 7, no. 10, pp. 374–378, 1996. View at: Publisher Site | Google Scholar
  54. C. S. Bauer, R. J. Woolley, A. G. Teschemacher, and E. P. Seward, “Potentiation of exocytosis by phospholipase C-coupled G-protein-coupled receptors requires the priming protein Munc13-1,” The Journal of Neuroscience, vol. 27, no. 1, pp. 212–219, 2007. View at: Publisher Site | Google Scholar

Copyright © 2019 Krisztián Sepp et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles